Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly applied for the treatment of cardiogenic shock despite its high complication rate.
Impella device is a small heart pump that pulls blood from the left ventricle through an inlet area near the tip and expels blood from the catheter into the ascending aorta. The device was inserted percutaneously through the femoral artery into the ascending aorta, via the aortic valve into the left ventricle. In compliance with the Declaration of Helsinki and in agreement with Italian and German data protection laws, we retrospectively collected data on patients with severe refractory cardiogenic shock from two tertiary critical care referral centers and enrolled 157 patients (January 2013 to April 2015): 123 received VA-ECMO support and 34 had concomitant treatment with VA-ECMO and Impella implanted simultaneously. The decision for an additional implantation of Impella was undertaken as the attending physician recognized signs of echocardiographic, radiological, and clinical signs of impaired left ventricle unloading or left ventricle stasis (stone heart, pulmonary edema, impending clotting on the left ventricle, significant aortic regurgitation). Impella was left running at P8 speed in order to produce a forward flow of 2.0 L without complications. A propensity-matching analysis was performed in a 2:1 ratio, resulting in 42 patients undergoing VA-ECMO alone (control group) compared with 21 patients treated with VA-ECMO and Impella. Patients in the VA-ECMO and Impella group had significantly lower hospital mortality (47% vs. 80%, P , 0.001) and a higher rate of successful bridging to either recovery or further therapy (68% vs. 28%, P , 0.001) compared with VA-ECMO patients. Other results are presented in Table 1. In conclusion, among different strategies to unload the left ventricle during VA-ECMO, Impella can be considered a feasible option. Nevertheless, randomized studies are warranted to validate this strategy.
Keywords: VA-ECMO, Impella, left ventricular distension, cardiogenic shock Table 1 . Comparison of major outcomes between patients treated with veno-arterial extracorporeal membrane oxygenation (ECMO) and Impella and patients treated with veno-arterial ECMO only in the propensity score matching sample (n ¼ 63).
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